Amyris Inc (NASDAQ: AMRS)
Amyris has been a very interesting stock to watch as of late, and for good reason. The year has been filled with press releases, new contracts, and more. Nonetheless, with a slight miss on earnings in the beginning of this month, there are many questioning whether or not it’s a good idea to get involved. Below, we’ll talk about what we’re seeing from the stock and why I believe that AMRS is a strong buy for the savvy investor.
What We’re Seeing From AMRS
Today is proving to be a great day in the market for Amyris. Since the opening bell, the stock has been running further and further into the green. Currently (10:43), AMRS is trading at $0.87 per share after a gain of $0.06 per share (7.86%) thus far today.
Why AMRS Is Fundamentally Strong
In my opinion, Amyris presents an opportunity that investors just don’t see too often. The company is trading like a company with no products for sale. However, there are products on the shelves that investors themselves can buy.
At the end of the day, 2016 has been a pivotal year for the company. Throughout the year, we’ve watched as the company announced several collaboration agreements and even launched a product that’s proving to be successful. While there are still financial hurdles AMRS is going to have to make it over, the company has set the foundation for strong growth ahead. For a list of the larger accomplishments the company has achieved this year, click here.
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will be keeping a very close eye on AMRS. First and foremost, we are going to be watching the progress of the collaboration agreements the company has signed throughout the year. We’re also looking forward to sales reports, future collaborations, and more. We’ll watch the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!
[Image Courtesy of Flickr]